Advertisement
Screener

MaxCyte, Inc. (MXCT) Net Margin

MaxCyte, Inc. (MXCT) Net Margin

  • 2026-06-30: Net Margin -179.78%.
  • 2026-03-31: Net Margin -105.53%.
  • 2025-12-31: Net Margin -200.46%.
  • 2025-09-30: Net Margin -269.74%.

Complete source-backed net margin history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-30-179.78%
2026-03-31-105.53%
2025-12-31-200.46%
2025-09-30-269.74%
2025-06-30-212.17%
2025-03-31-178.67%
2024-12-31-175.01%
2024-09-30-205.93%
2024-06-30-188.82%
2024-03-31-170.59%
2023-12-31-110.98%
2023-09-30-270.72%
2023-06-30-186.98%
2023-03-31-219.22%
2022-12-31-62.01%
2022-09-30-89.95%
2022-06-30-118.31%
2022-03-31-59.31%
2021-12-31-64.95%
2021-09-30-47.79%
2021-06-30-104.82%
2021-03-31-167.62%
2020-12-31-51.55%
2020-09-30-66.36%
2020-06-30-129.14%

Annual Net Margin

DateNet Margin
2025-12-31-212.96%
2024-12-31-184.81%
2023-12-31-194.51%
2022-12-31-81.99%
2021-12-31-88.46%
2020-12-31-76.47%
2019-12-31-97.27%

Similar stocks

Stock NameCountryMarket CapPE Ratio
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71
NRC HEALTH (NRC)United States$0.450B42.50
OmniAb, Inc. (OABI)United States$0.698B-8.05
Absci Corp (ABSI)United States$1.775B-14.92
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14